Lenograstim 5 µg/kg is not superior to biosimilar filgrastim 10 µg/kg in lymphoma patients undergoing peripheral blood stem cell mobilization after chemotherapy: preliminary results from a prospective randomized study.

Autor: Marchesi F; Hematology and Stem Cell Transplant Unit., Vacca M; Immuno-Transfusional Medicine, Leukapheresis and Cellular Therapy Unit, S. Camillo-Forlanini Hospital, Rome, Italy., Giannarelli D; Biostatistics Unit, Scientific Direction, IRCCS Regina Elena National Cancer Institute, Regina Elena National Cancer Institute., Ipsevich F; Immuno-Transfusional Medicine, Leukapheresis and Cellular Therapy Unit, S. Camillo-Forlanini Hospital, Rome, Italy., Pandolfi A; Immuno-Transfusional Medicine, Leukapheresis and Cellular Therapy Unit, S. Camillo-Forlanini Hospital, Rome, Italy., Gumenyuk S; Hematology and Stem Cell Transplant Unit., Renzi D; Hematology and Stem Cell Transplant Unit., Palombi F; Hematology and Stem Cell Transplant Unit., Pisani F; Hematology and Stem Cell Transplant Unit., Romano A; Hematology and Stem Cell Transplant Unit., Spadea A; Hematology and Stem Cell Transplant Unit., Papa E; Hematology and Stem Cell Transplant Unit., Canfora M; Biostatistics Unit, Scientific Direction, IRCCS Regina Elena National Cancer Institute, Regina Elena National Cancer Institute., Pierelli L; Immuno-Transfusional Medicine, Leukapheresis and Cellular Therapy Unit, S. Camillo-Forlanini Hospital, Rome, Italy., Mengarelli A; Hematology and Stem Cell Transplant Unit.

Publikováno v: Transfusion [Transfusion] 2018 May; Vol. 58 (5), pp. 1143-1148. Date of Electronic Publication: 2018 Feb 15.